EPHA2 and neoplasm: Iwahori et al., for example, engineered T cells to secrete BiTEs specific for CD3 and the tumour-associated antigen EphA2, a receptor tyrosine kinase overexpressed in a broad range of solid cancers that has recently been implicated in tumour metastases.